Peri̇han Ünak

1.1k total citations
90 papers, 895 citations indexed

About

Peri̇han Ünak is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Peri̇han Ünak has authored 90 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Peri̇han Ünak's work include Radiopharmaceutical Chemistry and Applications (44 papers), Nanoparticle-Based Drug Delivery (12 papers) and Medical Imaging Techniques and Applications (11 papers). Peri̇han Ünak is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (44 papers), Nanoparticle-Based Drug Delivery (12 papers) and Medical Imaging Techniques and Applications (11 papers). Peri̇han Ünak collaborates with scholars based in Türkiye, United States and Singapore. Peri̇han Ünak's co-authors include Fazilet Zümrüt Biber Müftüler, Emin İlker Medine, Fatma Yurt, Suna Tımur, Serhan Sakarya, Özge Kozguş Güldü, Ayfer Yurt Kılçar, Berkan Çetinkaya, Şükran Darcan and Kübra Durkan and has published in prestigious journals such as PLoS ONE, Journal of Materials Chemistry and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Peri̇han Ünak

86 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peri̇han Ünak Türkiye 16 299 175 132 128 114 90 895
Fazilet Zümrüt Biber Müftüler Türkiye 15 271 0.9× 161 0.9× 86 0.7× 125 1.0× 122 1.1× 108 840
Aruna Korde India 20 388 1.3× 161 0.9× 55 0.4× 156 1.2× 151 1.3× 68 875
Emin İlker Medine Türkiye 15 197 0.7× 199 1.1× 161 1.2× 95 0.7× 82 0.7× 78 683
Perıhan Ünak Türkiye 14 205 0.7× 133 0.8× 60 0.5× 74 0.6× 94 0.8× 70 589
Milan Lázníček Czechia 15 241 0.8× 141 0.8× 95 0.7× 235 1.8× 98 0.9× 68 713
Marina Sagnou Greece 21 182 0.6× 295 1.7× 99 0.8× 257 2.0× 106 0.9× 57 1.3k
Ali Khalaj Iran 17 208 0.7× 287 1.6× 46 0.3× 154 1.2× 91 0.8× 93 975
Tamer M. Sakr Egypt 24 471 1.6× 380 2.2× 329 2.5× 164 1.3× 217 1.9× 83 1.5k
Robert Kaplánek Czechia 20 104 0.3× 343 2.0× 43 0.3× 99 0.8× 83 0.7× 62 1.1k
Katsumi Hayashi Japan 18 126 0.4× 131 0.7× 25 0.2× 90 0.7× 192 1.7× 147 1.3k

Countries citing papers authored by Peri̇han Ünak

Since Specialization
Citations

This map shows the geographic impact of Peri̇han Ünak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peri̇han Ünak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peri̇han Ünak more than expected).

Fields of papers citing papers by Peri̇han Ünak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peri̇han Ünak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peri̇han Ünak. The network helps show where Peri̇han Ünak may publish in the future.

Co-authorship network of co-authors of Peri̇han Ünak

This figure shows the co-authorship network connecting the top 25 collaborators of Peri̇han Ünak. A scholar is included among the top collaborators of Peri̇han Ünak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peri̇han Ünak. Peri̇han Ünak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ocak, Meltem, et al.. (2023). Targeted Alpha Radionuclide Therapy (TAT)-Ac-225 Radiopharmaceuticals. 9(1). 16–24.
3.
Ünak, Peri̇han, et al.. (2022). INVESTIGATIONS OF 44Ti PRODUCTION FOR 44Ti/44Sc RADIONUCLIDE GENERATOR. DergiPark (Istanbul University). 1 indexed citations
4.
Ünak, Peri̇han, et al.. (2021). Effects of fluorodeoxyglucose magnetic nanoparticles on NCI-H727 and SH-SY5Y cancer cells.. PubMed. 4(1). 53–66. 1 indexed citations
5.
Barlas, Fırat Barış, et al.. (2020). Protoporphyrin‐IX and Manganese Oxide Nanoparticles Encapsulated in Niosomes as Theranostic. ChemistrySelect. 5(6). 1987–1993. 5 indexed citations
6.
Güldü, Özge Kozguş, Serap Evran, Emin İlker Medine, et al.. (2014). Isolation and Immobilization of His-Tagged Alcohol Dehydrogenase on Magnetic Nanoparticles in One Step: Application as Biosensor Platform. Journal of Macromolecular Science Part A. 51(9). 699–705. 4 indexed citations
7.
Ünak, Peri̇han, Fazilet Zümrüt Biber Müftüler, Emin İlker Medine, et al.. (2013). Investigation of Therapeutic Efficiency of Bleomycin and Bleomycin-Glucuronide Labeled with 131 I on the Cancer Cell Lines. Cancer Biotherapy and Radiopharmaceuticals. 28(4). 310–319. 5 indexed citations
8.
Ünak, Peri̇han, et al.. (2012). Radiolabeling of Bleomycin-Glucuronide with 131 I and Biodistribution Studies Using Xenograft Model of Human Colon Tumor in Balb/C Mice. Cancer Biotherapy and Radiopharmaceuticals. 27(6). 371–383. 7 indexed citations
9.
Müftüler, Fazilet Zümrüt Biber, et al.. (2011). 99m Tc-D-Penicillamine-Glucuronide: Synthesis, Radiolabeling, In Vitro and In Vivo Evaluation. Cancer Biotherapy and Radiopharmaceuticals. 26(5). 623–630. 4 indexed citations
10.
Ünak, Peri̇han, et al.. (2011). Metabolic Comparison of Radiolabeled Bleomycin and Bleomycin-Glucuronide Labeled with 99m Tc. Cancer Biotherapy and Radiopharmaceuticals. 26(5). 573–584. 5 indexed citations
11.
Müftüler, Fazilet Zümrüt Biber, et al.. (2011). Effect of a plant origin drug on the biodistribution of 99mTc-DTPA in Wistar albino rats. Revista Brasileira de Farmacognosia. 22(2). 344–349. 5 indexed citations
12.
Müftüler, Fazilet Zümrüt Biber, et al.. (2011). Effects of broccoli extract on biodistribution and labeling blood components with 99mTc-GH. Acta Cirúrgica Brasileira. 26(5). 339–345. 10 indexed citations
13.
Medine, Emin İlker, et al.. (2010). Enzymatic Synthesis of Uracil Glucuronide, Labeling with 125/131 I, and In Vitro Evaluation on Adenocarcinoma Cells. Cancer Biotherapy and Radiopharmaceuticals. 25(3). 335–344. 10 indexed citations
14.
Ünak, Peri̇han, et al.. (2010). In vivo biodistribution of 131I labeled bleomycin (BLM) and isomers (A2 and B2) on experimental animal models. Journal of Radioanalytical and Nuclear Chemistry. 285(2). 207–214. 8 indexed citations
15.
Cemek, Mustafa, et al.. (2007). Effect of grape seed extract on lipid peroxidation, antioxidant activity and peripheral blood lymphocytes in rats exposed to x‐radiation. Phytotherapy Research. 21(11). 1029–1035. 31 indexed citations
16.
Müftüler, Fazilet Zümrüt Biber, et al.. (2005). Synthesis of DTPA-attached estradiol derivative and determination of its radiopharmaceutical potential. Journal of Radioanalytical and Nuclear Chemistry. 266(3). 445–454. 7 indexed citations
17.
Ünak, Peri̇han, et al.. (2004). Stability constants of , Th4+and Ce3+withL-asparagine and thermodynamic parameters. Physics and Chemistry of Liquids. 42(6). 569–575. 2 indexed citations
18.
Ünak, Peri̇han, et al.. (2002). A correlative study between 99mTc-ESTCPTA and 99mTc-MIBI in rats. Applied Radiation and Isotopes. 57(5). 733–742. 6 indexed citations
19.
Müftüler, Fazilet Zümrüt Biber, et al.. (1999). Determination of iodide in common salts consumed in Turkey by isotope dilution analysis. Journal of Radioanalytical and Nuclear Chemistry. 240(1). 395–396. 5 indexed citations
20.
Ünak, Peri̇han, et al.. (1996). Direct radioiodination of metabolic 8-hydroxy-quinolyl-glucuronide, as a potential anti-cancer drug. Applied Radiation and Isotopes. 47(7). 645–647. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026